Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Achieve Life Sciences Inc (ACHV)  
$5.66 0.10 (1.8%) as of 4:30 Mon 1/12


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 34,340,000
Market Cap: 194.36(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.975 - $5.47
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Diagnostic Substances

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Achieve Life Sciences is a pharmaceutical company engaged in the development and commercialization of cytisinicline for smoking cessation and nicotine addiction. Co.'s product candidate, cytisinicline, is a naturally occurring plant-based alkaloid from the seeds of the Laburnum anagyroides plant. Cytisinicline is structurally similar to nicotine and has a dual-acting mechanism of action that is both agonistic and antagonistic. Cytisinicline interacts with nicotine receptors in the brain by reducing the severity of nicotine withdrawal symptoms through agonistic binding to nicotine receptors and by reducing the reward and satisfaction associated with nicotine through antagonistic properties.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 20,000 40,000
Total Buy Value $0 $0 $57,485 $149,185
Total People Bought 0 0 2 3
Total Buy Transactions 0 0 2 4
Total Shares Sold 0 381,972 381,972 381,972
Total Sell Value $0 $1,084,997 $1,084,997 $1,084,997
Total People Sold 0 6 6 6
Total Sell Transactions 0 6 6 6
End Date 2025-10-12 2025-07-11 2025-01-10 2024-01-11

   
Records found: 142
  Page 1 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Rubinstein Mark Lawrence Chief Medical Officer   •       –      –    2026-01-01 3 IO $0.00 $0 D/D 0 39,600     -
   Stewart Richard Alistair Chief Executive Officer   •       •      –    2025-09-18 4 S $2.92 $378,143 D/D (129,501) 228,875 -94%     
   Stewart Richard Alistair Chief Executive Officer   •       •      –    2025-09-18 4 OE $0.00 $0 D/D 297,500 358,376     -
   Oki Mark K Chief Financial Officer   •       –      –    2025-09-18 4 S $2.92 $146,175 D/D (50,060) 127,940 -94%     
   Oki Mark K Chief Financial Officer   •       –      –    2025-09-18 4 OE $0.00 $0 D/D 168,000 178,000     -
   Donnelly Craig Chief Operations Officer   •       –      –    2025-09-08 3 IO $0.00 $0 D/D 0 52,372 90%     
   Wann Jerry Principal Accounting Officer   •       –      –    2025-09-04 4 S $2.77 $38,974 D/D (14,070) 32,694 -99%     
   Wann Jerry Principal Accounting Officer   •       –      –    2025-09-04 4 OE $0.00 $0 D/D 34,100 46,764     -
   King Thomas Braxton   –       •      –    2025-09-04 4 S $2.77 $387,407 D/D (139,858) 315,142 -99%     
   King Thomas Braxton   –       •      –    2025-09-04 4 OE $0.00 $0 D/D 455,000 455,000     -
   Jacobs Cindy President & CMO   •       –      –    2025-09-04 4 S $2.77 $76,532 D/D (27,629) 115,585 -99%     
   Jacobs Cindy President & CMO   •       –      –    2025-09-04 4 OE $0.00 $0 D/D 110,000 143,214     -
   Xinos Jaime Chief Commercial Officer   •       –      –    2025-09-04 4 S $2.77 $57,766 D/D (20,854) 74,432 -99%     
   Xinos Jaime Chief Commercial Officer   •       –      –    2025-09-04 4 OE $0.00 $0 D/D 69,000 95,286     -
   Oki Mark K Chief Financial Officer   •       –      –    2025-03-17 4 B $2.89 $28,887 D/D 10,000 10,000 0.01 -8%     
   Stewart Richard Alistair Chieve Executive Officer   •       •      –    2025-03-17 4 B $2.86 $28,598 D/D 10,000 60,876 0.01 -8%     
   Xinos Jaime Chief Commercial Officer   •       –      –    2024-10-15 3 IO $0.00 $0 D/D 0 26,293 -39%     
   Wann Jerry Principal Accounting Officer   •       –      –    2024-08-16 4 A $3.67 $10,485 D/D 2,857 12,664     -
   Jacobs Cindy President & CMO   •       •      –    2024-08-16 4 A $3.67 $9,762 D/D 2,660 33,214     -
   Bencich John CEO   •       •      –    2024-08-16 4 A $3.67 $18,350 D/D 5,000 100,636     -
   Wann Jerry Principal Accounting Officer   •       –      –    2024-04-19 4 D $4.51 $10,148 D/D (2,250) 9,807     -
   Wann Jerry Principal Accounting Officer   •       –      –    2024-04-19 4 OE $0.00 $0 D/D 5,625 12,057     -
   Stewart Richard Alistair Executive Chairman   •       •      –    2024-04-19 4 D $4.51 $45,664 D/D (10,125) 50,876     -
   Stewart Richard Alistair Executive Chairman   •       •      –    2024-04-19 4 OE $0.00 $0 D/D 22,500 61,001     -
   Jacobs Cindy President & CMO   •       •      –    2024-04-19 4 D $4.51 $17,846 D/D (3,957) 30,554     -
  142 Records found
  1  2  3  4  5  6   
  Page 1 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2026 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us